
THERMO FISHER SCIENT. CDR
Aktie · CA88355G1000 · A404RW (XFRA)
Kein Kurs
Schlusskurs XFRA 16.12.2025:
12,10 EUR
16.12.2025 14:29
Aktuelle Kurse von THERMO FISHER SCIENT. CDR
| Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
|---|---|---|---|---|---|
![]() Frankfurt |
TN80.F
|
EUR
|
16.12.2025 14:29
|
12,10 EUR
| -0,10 EUR
-0,82 %
|
![]() Quotrix |
TFSIRS00.DUSD
|
EUR
|
16.12.2025 06:27
|
12,90 EUR
| 0,70 EUR
+5,74 %
|
![]() Düsseldorf |
TFSIRS00.DUSB
|
EUR
|
15.12.2025 18:32
|
12,30 EUR
| -0,10 EUR
-0,81 %
|
Firmenprofil zu THERMO FISHER SCIENT. CDR Aktie
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Unternehmensdaten
Name THERMO FISHER SCIENT. CDR
Firma Thermo Fisher Scientific Inc.
Website
https://www.thermofisher.com
Heimatbörse
Frankfurt
Frankfurt
WKN A404RW
ISIN CA88355G1000
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Marc N. Casper
Marktkapitalisierung 292 Mrd.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 125,0 T
Adresse 168 Third Avenue, 02451 Waltham
IPO Datum 2024-02-15
Ticker Symbole
| Name | Symbol |
|---|---|
| Düsseldorf | TFSIRS00.DUSB |
| Frankfurt | TN80.F |
| Quotrix | TFSIRS00.DUSD |
Weitere Aktien
Investoren, die THERMO FISHER SCIENT. CDR halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.





